Skip to main content
. 2022 Oct 26;7(44):40230–40240. doi: 10.1021/acsomega.2c05111

Figure 1.

Figure 1

Biomarker analysis of serum N-glycan abundance comparing lung cancer patients and healthy volunteers. (A) Scores plot showing distribution of cancer patients (red) and healthy volunteers (green) across components 1 and 2 given the OPLS-DA model for serum N-glycans. (B) ROC curve analysis of serum N-glycans.